Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

AQR Manager Asness Moves into Mutual Funds

AQR Capital Management founder Cliff Asness is a high-flyer. Even within the hedge fund industry, which is notoriously tough, the 45-year-old Asness has managed to grow his AQR Capital to $42 billion in assets under management, which makes his fund one of the top players in hedge funds. Asness “is a Ph.D… who narrowly chose managing money over a professorship and remains influential in academic circles. That’s the elixir for his success, reports Fortune. AQR CAPITAL MANAGEMENT

“When he designs a market-beating strategy, his data are so convincing that he gets the research community overwhelmingly on his side. The sway of his science gives him just the right pitch to keep gathering assets from America’s big institutional investors.”

But, why stop there? Asness has begun to move into largely uncharted area for a hedge fund manager – mutual funds. “Asness is now offering sophisticated strategies to the broad public that for years have been available only to institutional clients,” writes Fortune. Not to be dramatic, but the move could reshape the investing world. On the one hand, there will be imitators. AQR has nine mutual funds right now with combined assets at $5.5 billion – certainly not a number to turn your nose up at and other funds are going to want a piece of the action. JP Morgan’s Highbridge Capital currently has seven mutual funds. On the other hand, AQR is offering a sophisticated investment product at a low price – mutual funds don’t have the high management and performance fees hedge funds do. Given poor hedge fund performance across the board and the fact that Asness is offering essentially the same product, investors will soon start questioning the validity of the much higher high hedge fund fees.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!